Tradestie Institutional Equity Comparison Engine

INBX vs KYMR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

KYMR Overall Edge

KYMR Captures Institutional Edge (3โ€“0 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Kymera Therapeutics, Inc. Common Stock (KYMR) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, INBX trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus KYMR at N/M Forward P/E and -396.0% operating margin (+466.4% YoY). In options structure, INBX sits in BREAKDOWN (8th %ile IV; Dealer Gamma Walls on Pro) against KYMR sits in CONSOLIDATION (23rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
INBX N/M vs KYMR N/M Fwd P/E
Growth & Margin Winner KYMR
Op Margin 0.0% vs -396.0% ยท YoY -100.0% vs +466.4%
Momentum & Technical Winner KYMR
1Y +3.6% vs +96.1% ยท 52W Pos 20% vs 78%
Options & Structure Winner KYMR
BREAKDOWN (8th %ile IV) vs CONSOLIDATION (23rd %ile IV)
INBX NASDAQ
Inhibrx Biosciences, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$77.32
-7.18% 1D
Market Cap $1.3B
1M Return -13.93%
1Y Return +3.61%
Forward P/E N/M
Unified AI Score
51.4 / 100 HOLD
Tech 48.0 Fund 55.0 Flow 68.0 Mom 50.0
KYMR NASDAQ
Kymera Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$124.79
-2.18% 1D
Market Cap $10.9B
1M Return +19.1%
1Y Return +96.12%
Forward P/E N/M
Unified AI Score
47.1 / 100 HOLD
Tech 36.0 Fund 50.0 Flow 67.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: INBX +3.61% KYMR +96.12% Spread: +92.51 pp (KYMR Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period INBX Revenue KYMR Revenue INBX Op. Margin KYMR Op. Margin Margin Edge
FY2019 N/A $0M N/A -1438.5% KYMR
FY2020 N/A $30M N/A -136.1% KYMR
FY2021 N/A $70M N/A -138.0% KYMR
FY2022 N/A $50M N/A -344.4% KYMR
FY2023 $0M $80M -12178.9% -210.6% KYMR
FY2024 $0M $50M -165724.0% -555.8% KYMR
FY2025 $0M $40M -10386.5% -891.1% KYMR

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: INBX (2) vs KYMR (5)
Institutional Metric INBX KYMR Criterion Row Winner
Market Capitalization Scale $1.3B $10.9B Larger Scale KYMR
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -100.0% +466.4% Higher Growth KYMR
Operating Margin (TTM) Profitability 0.0% -396.0% Higher Margin INBX
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -1773.6% -27.3% Higher ROE KYMR
52-Week Range Position Momentum 20% ($57โ€“$155) 78% ($62โ€“$143) Stronger Trend KYMR
Beta / 30D Volatility Risk Regime 2.53ฮฒ ยท 120% Vol 1.04ฮฒ ยท 54% Vol Lower Realized Risk KYMR
Unified Institutional Score Composite Signal 51.4 / 100 (HOLD) 47.1 / 100 (HOLD) Higher Composite INBX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full INBX vs KYMR Buy Guide
INBX BREAKDOWN
134d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live INBX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
KYMR CONSOLIDATION
62d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 23rd %ile
IV Regime Compressed (<25th %ile)
Live KYMR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither INBX nor KYMR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.